Literature DB >> 9252926

Thalidomide in oral Crohn's disease refractory to conventional medical treatment.

E B Odeka, V Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9252926

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  4 in total

Review 1.  Immunomodulation by thalidomide and thalidomide analogues.

Authors:  L G Corral; G Kaplan
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

Review 3.  Thalidomide in gastrointestinal disorders.

Authors:  A Bousvaros; B Mueller
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Pediatric Inflammatory Bowel Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.